Latest News by Industry
MENLO PARK, Calif. (AP) — MENLO PARK, Calif. (AP) — Corcept Therapeutics Inc. (CORT) on Tuesday reported fourth-quarter earnings of $16.6 million.
The Menlo Park, California-based company said it had profit of 14 cents per share.
The drug developer posted revenue of $103.1 million in the period, falling short of Street forecasts. Four analysts surveyed by Zacks expected $103.7 million.
For the year, the company reported profit of $101.3 million, or 87 cents per share. Revenue was reported as $401.9 million.
Corcept expects full-year revenue in the range of $430 million to $450 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a CORT">Zacks stock report on CORT at https://www.zacks.com/ap/CORT